DUBLIN (AP) — DUBLIN (AP) — Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported fourth-quarter profit of $191.1 million.
The Dublin-based company said it had profit of $3.11 per share. Earnings, adjusted for one-time gains and costs, were $6.60 per share.
The results topped Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $5.79 per share.
The drugmaker posted revenue of $1.09 billion in the period, also surpassing Street forecasts. Ten analysts surveyed by Zacks expected $1.06 billion.
For the year, the company reported profit of $560.1 million, or $8.65 per share. Revenue was reported as $4.07 billion.
Jazz expects full-year earnings in the range of $22.50 to $24 per share, with revenue in the range of $4.15 billion to $4.4 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JAZZ at https://www.zacks.com/ap/JAZZ
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
